Filter your results
- 3
- 3
- 3
- 2
- 1
- 3
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsScience, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles
hal-02126484v1
|
|||
|
Immune classifications with cytotoxic CD8(+) and Th17 infiltrates are predictors of clinical prognosis in glioblastoma.OncoImmunology, 2017, 6 (6), pp.e1321186. ⟨10.1080/2162402X.2017.1321186⟩
Journal articles
hal-01575570v1
|
||
|
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapyBritish Journal of Cancer, 2018, 119 (8), pp.950-960. ⟨10.1038/s41416-018-0220-9⟩
Journal articles
hal-01980112v1
|